ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.
March 13, 2025
Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split
August 27, 2021
Related Post
-
-
Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity
March 6, 2025
-
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
-
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 6, 2025